Dr. Siddheshwar Chauthe - National Institute of Pharmaceutical Education & Research, Ahmedabad

Dr. Siddheshwar Chauthe, Ph.D

Bioassay-guided isolation, structure elucidation and synthetic modification of bioactive compounds from medicinal plants.
Development of analytical methods for standardization of medicinal plant extracts and polyherbal formulations using hyphenated techniques.
To develop integrated strategy for the validation of substitute plants (AbhavPratinidhi Dravya) for the endangered medicinal plants used in traditional medicine

March 2025 to Present
Associate Professor
Department of Natural Products, NIPER Ahmedabad
March 2020 to March 2025
Assistant Professor
Department of Natural Products, NIPER Ahmedabad
October 2019 to March 2020
Senior Research Investigator (Team Lead LCMS and HPLC Sections)
Biocon-BMS R&D Center (BBRC), Syngene International Ltd, Bangalore
April 2016 to September 2019
Research Investigator (Team Lead LCMS and HPLC Sections)
Biocon-BMS R&D Center (BBRC), Syngene International Ltd, Bangalore
March 2014 to Nov 2015
Research Specialist-II (Post Doc)
Metabolomics Center, Georgetown University Medical Center, USA
June 2012 to March 2014
Assistant Manager
Pharmaceutical R&D, GlaxoSmithKline, Nashik, India
March 2005 to Aug 2006
Research Associate
R & D, Piramal Life Sciences, Limited, Mumbai
May 2004 to Dec 2005
R&D Officer
R & D, Sami Labs Limited, Bangalore

Investigator- Initiated Research Proposals for Small Extramural Grants (ICMR) (IIRPSG-2025-01-00637)
National Medicinal Plants Board, Ministry of AYUSH, Government of India
Centre for Medical Devices (CMD), NIPER–Ahmedabad
Industrial contract research project from Procter & Gamble Health Limited, Mumbai, 2023
Industrial consultancy project from Procter & Gamble Health Limited, Mumbai. 2021
Industrial consultancy project from Procter & Gamble Health Limited, Mumbai, 2022
Industrial consultancy project from Procter & Gamble Health Limited, Mumbai 2023

Patent Title: Tumor Necrosis Factor – Alpha Inhibitors
Patent application No: WO2008142623
Patent Status: Filed.
Patent Title: Novel dimeric phloroglucinol compounds as anti-HIV and microbicidal agents.
Patent Status: Granted (289013)
Patent Title: Pyranoacridone Compounds And Process For Preparation Thereof.
Patent Status: Granted (543661)
Patent Title: Polyherbal Formulation Containing Slow Eroding Extrudate for Treatment of Mouth Ulcer
Patent application No: 202321008552
Patent Status: Filed.